The rheumatology month in review for June 2024 addresses the critical role of psychological, socioeconomic, and lifestyle factors in the management of rheumatic diseases, particularly rheumatoid...
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | Reuters Novo Nordisk investors appeared...
Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor...
Diana Girnita, MD, PhD, founder and CEO of Rheumatologist OnCall, has a thriving YouTube channel with nearly 100K subscribers and over 500 videos to date. She...
Our ophthalmology month in review for June 2024 focuses on updates to the pipeline, a look at the impact of vision problems on public health in...
Eduardo Cuevas | USA TODAY Health officials detail bird flu transmission to humans. What we know. Health officials are urging caution with where consumers get their...
It was a far cry from the year prior, when Pfizer’s shares plunged more than 40%, making it one of the worst-performing large pharmaceutical stocks of...
Credit: Unsplash/Bady Abbas A recent investigation in JAMA Ophthalmology evaluated the frequency of topical antibiotic treatment and its association with healthcare use among children and adolescents...
Researchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive to chemotherapy, while...
Jennifer Goldman, RPh, PharmDCredit: Massachusetts College of Pharmacy Since the turn of the century, diabetes management has seen, and is still in the midst of, dramatic...
Developed a ‘Niclosamide-based multi-treatment drug’ that can simultaneously treat mosquito-borne viral infections such as four serotypes of dengue virus, Zika, Chikungunya, and Yellow Fever. Accelerating preparations...
Richard Pratley, MDCredit: Advent Health Diabetes Institute Exactly 1 month after its original presentation at the 61st European Renal Association Congress, the FLOW trial and semaglutide...